UBS AG's U.S. brokerage business has stopped selling exchange-traded funds that use leverage because the products do not conform to its emphasis on long-term investing.

The Zurich company's UBS Wealth Management Americas unit suspended sales of inverse and leveraged exchange-raded funds immediately, citing the "short-term nature of these securities," the New York brokerage unit said Monday.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.